Benito-Garcia Filipe, Pires Inês, Lima Jorge
Immunoallergy Department, CUF Descobertas Hospital, 1998-018 Lisbon, Portugal.
São Bernardo Hospital, Centro Hospitalar de Setúbal, 2910-549 Setúbal, Portugal.
Medicina (Kaunas). 2021 Apr 17;57(4):390. doi: 10.3390/medicina57040390.
Low-dose acetylsalicylic acid (ASA) is widely used during pregnancy to prevent obstetric complications of placental dysfunction, such as preeclampsia, stillbirth and fetal growth restriction, and obstetric complications in pregnant women with antiphospholipid syndrome. ASA-sensitive pregnant women cannot benefit from the effects of ASA due to the possibility of severe or potentially life-threatening hypersensitivity reactions to ASA. ASA desensitization is a valuable and safe therapeutic option for these women, allowing them to start daily prophylaxis with ASA and prevent pregnancy complications. The authors discuss the recent advances in obstetric conditions preventable by ASA and the management of ASA hypersensitivity in pregnancy, including ASA desensitization. To encourage the implementation of ASA desensitization protocols in ASA-sensitive pregnant women, they also propose a practical approach for use in daily clinical practice.
低剂量阿司匹林(ASA)在孕期被广泛用于预防胎盘功能障碍的产科并发症,如先兆子痫、死产和胎儿生长受限,以及抗磷脂综合征孕妇的产科并发症。由于对ASA可能发生严重或潜在危及生命的过敏反应,对ASA敏感的孕妇无法从ASA的作用中获益。ASA脱敏是这些女性一种有价值且安全的治疗选择,使她们能够开始每日服用ASA进行预防并预防妊娠并发症。作者讨论了可通过ASA预防的产科疾病的最新进展以及孕期ASA过敏的管理,包括ASA脱敏。为鼓励在对ASA敏感的孕妇中实施ASA脱敏方案,他们还提出了一种用于日常临床实践的实用方法。